PortnoyLaw_LogoHighResRoundLogoOnly.jpg
Kyverna Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. February 7, 2025 Deadline to file Lead Plaintiff Motion
24. Januar 2025 18:13 ET | Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Jan. 24, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Kyverna Therapeutics, Inc....
Block & Leviton LLP Logo
KYVERNA THERAPEUTICS ALERT: Securities Fraud Lawsuit Could Allow Investors to Recover Losses; Block & Leviton Encourages Shareholders to Contact The Firm
23. Dezember 2024 08:22 ET | Block & Leviton LLP
Kyverna Therapeutics has been sued for securities fraud. Block & Leviton encourages investors to contact the firm to learn how they might recover losses.
DL_Logo-side-by-side.png
INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Kyverna Therapeutics, Inc. (Nasdaq: KYTX); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel
12. Dezember 2024 18:34 ET | DiCello Levitt LLP
SAN DIEGO, Dec. 12, 2024 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of all persons and entities who purchased or otherwise acquired Kyverna Therapeutics, Inc. (Nasdaq: KYTX)...
PortnoyLaw_LogoHighResRoundLogoOnly.jpg
Kyverna Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. February 7, 2025 Deadline to file Lead Plaintiff Motion.
10. Dezember 2024 18:12 ET | Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Kyverna Therapeutics, Inc....
Block & Leviton LLP Logo
Kyverna Therapeutics, Inc. Investors Who Have Lost Money Should Contact Block & Leviton to Find Out How They Might Recover Money Through A Recent Securities Lawsuit
09. Dezember 2024 18:38 ET | Block & Leviton LLP
Block & Leviton announces that a securities fraud lawsuit has been filed against Kyverna Therapeutics (Nasdaq: KYTX). Investors should contact the firm.